01 1Atidarsagen Autotemcel
02 1BUROSUMAB-TWZA
03 21Burosumab
04 1CD34+ Cell-Enriched Population Transduced with Lentiviral Vector Encoding Human Arylsulfatase A Gene, Autologous Human
05 2Droperidol
06 1Evocalcet
07 14Fentanyl
08 1Fentanyl Citrate
09 2Granisetron
10 2ISTRADEFYLLINE
11 1MOGAMULIZUMAB-KPKC
12 4Mitomycin
13 2Mogamulizumab
14 1Mogamulizumabum
15 2Nitroglycerin
16 1TOREMIFENE CITRATE
17 2Testosterone
18 6naloxegol
01 5KYOWA KIRIN
02 6KYOWA KIRIN AUSTRALIA PTY LTD
03 9KYOWA KIRIN LIMITED
04 1Kyowa Kirin
05 7Kyowa Kirin Holdings B.V.
06 7Kyowa Kirin Holdings Bv
07 20Kyowa Kirin Limited
08 4Kyowa Kirin S?rl
09 2Orchard Therapeutics (Netherlands) Bv
10 2PROSTRAKAN LTD
11 1ProStrakan Ltd
12 1Prostrakan Ltd
01 6Antic-calc Tablet, Film Coated
02 1Concentrate For Infusion Solution
03 2Concentrate For Solution For Infusion
04 1Dispersion For Perfusion
05 1Fentanyl 100Mcg 10 Units Sublingual Use
06 1Fentanyl 200Mcg 10 Units Sublingual Use
07 1Fentanyl 300Mcg 10 Units Sublingual Use
08 1Fentanyl 400Mcg 10 Units Sublingual Use
09 1Fentanyl 600Mcg 10 Units Sublingual Use
10 1Fentanyl 800Mcg 10 Units Sublingual Use
11 1Gel
12 1Granisetrone 3,1Mg 1 Unit Transdermal Use
13 2INJECTABLE;INJECTION
14 1Infusion Solution
15 7Injectable Solution
16 3Injectable Solution In Pre-Filled Syringe
17 1Injection fluid, resolution
18 1Mitomycin 10Mg 1 Unit Parenteral Use
19 1Mitomycin 40Mg 1 Unit Parenteral Use
20 1Rectal Salve
21 8Solution For Injection
22 1Sublingual Tablet
23 8Sublingual tablet
24 3TABLET;ORAL
25 1Tablet
26 1Transdermal patches
27 8Blank
01 11 transdermal patch 3.1 mg/24 die
02 11 vial EV 10 mg
03 11 vial EV 40 mg
04 110 cpr subling 100 mcg
05 110 cpr subling 200 mcg
06 110 cpr subling 300 mcg
07 110 cpr subling 400 mcg
08 110 cpr subling 600 mcg
09 110 cpr subling 800 mcg
10 2100 mcg
11 210MG
12 110MG/ML
13 210mg
14 110mg/ml
15 212.5 mg
16 11mg/ml
17 12%
18 12-10millioncells/ml
19 12.5 mg/ml
20 12.5mg/ml
21 2200 mcg
22 320MG
23 120MG/5ML
24 220mg
25 120mg/ml
26 425 mg
27 13.1 mg/24 hours
28 1300 mcg
29 230MG
30 230mg
31 130mg/ml
32 14 mg/g
33 1400 mcg
34 140MG
35 24MG
36 14mg/5ml
37 14mg/ml
38 150mcg
39 1600 mcg
40 1800 mcg
41 1EQ 60MG BASE
42 1Gel 60 G 2%
43 1Ung Rett 30 G 4 Mg/G
44 8Blank
01 6Australia
02 11Italy
03 1Japan
04 18Norway
05 8Spain
06 12Sweden
07 4Switzerland
08 5USA
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Dispersion For Perfusion
Brand Name : Libmeldy 2-
Dosage Strength :
Packaging :
Approval Date : 2021-10-19
Application Number : 1201493001
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Injectable Solution
Brand Name : Crysvita
Dosage Strength : 10mg
Packaging :
Approval Date : 19/02/2018
Application Number : 20161206000011
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Solution For Injection
Brand Name : Crysvita
Dosage Strength : 10mg
Packaging :
Approval Date : 30/11/2023
Application Number : 20230530000063
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Injectable Solution
Brand Name : Crysvita
Dosage Strength : 20mg
Packaging :
Approval Date : 19/02/2018
Application Number : 20161206000028
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Solution For Injection
Brand Name : Crysvita
Dosage Strength : 20mg
Packaging :
Approval Date : 30/11/2023
Application Number : 20230530000070
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Injectable Solution
Brand Name : Crysvita
Dosage Strength : 30mg
Packaging :
Approval Date : 19/02/2018
Application Number : 20161206000035
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Solution For Injection
Brand Name : Crysvita
Dosage Strength : 30mg
Packaging :
Approval Date : 30/11/2023
Application Number : 20230530000087
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Solution For Injection
Brand Name : Crysvita
Dosage Strength : 10mg/ml
Packaging :
Approval Date : 20/01/2020
Application Number : 66801
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Solution For Injection
Brand Name : Crysvita
Dosage Strength : 20mg/ml
Packaging :
Approval Date : 20/01/2020
Application Number : 66801
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Solution For Injection
Brand Name : Crysvita
Dosage Strength : 30mg/ml
Packaging :
Approval Date : 20/01/2020
Application Number : 66801
Regulatory Info : Allowed
Registration Country : Switzerland
Kyowa Kirin is a supplier offers 7 products (APIs, Excipients or Intermediates).
Find a price of 7-Hydroxystaurosporine bulk offered by Kyowa Kirin
Find a price of Istradefylline bulk offered by Kyowa Kirin
Find a price of Olopatadine Hydrochloride bulk offered by Kyowa Kirin
Find a price of RGI-2001 bulk offered by Kyowa Kirin
Find a price of Spicamycin Analog bulk offered by Kyowa Kirin
Find a price of KW-6356 DRUG SUBSTANCE bulk offered by Kyowa Kirin
Find a price of ASKP1240 MONOCLONAL ANTIBODY DRUG SUBSTANCE AND DRUG PRODUCT bulk offered by Kyowa Kirin
